References
Abrahamsson, P. A. (2009). Prostate cancer: To treat or not to treat? European Urology Supplements, 8, 418-423. doi:10.1016/j.eursup .2009.01.007
Albertsen, P. C. (2011). When is active surveillance the appropriate treatment for prostate cancer? Acta Oncologica, 50(Suppl. 1), 120-126. doi:10.3109/0284186X.2010.526634
Bailey, D., Wallace, M., Landerman, R., Albala, D., Polascik, T., & Robertson, C. (2009). Psychosocial trajectories of men undergoing active surveillance for prostate cancer [Abstract 3902]. Oncology Nursing Forum. Retrieved from
http://ons.metapress.com/content/b768w05v4u151322/fulltext.pdf http://ons.metapress.com/content/b768w05v4u151322/fulltext.pdf
Bailey, D. E., Mishel, M. H., Belyea, M., Stewart, J. L., & Mohler, J. (2004). Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nursing, 27, 339-346. doi:10.1097/00002820-2004 09000-00001
Bailey, D. E., Wallace, M., Latini, D. M., Hegarty, J., Carroll, P. R., Klein, E. A., & Albertsen, P. C. (2011). Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Applied Nursing Research, 24, 193-199.
Bailey, D. E., Wallace, M., & Mishel, M. H. (2007). Watching, waiting, and uncertainty in prostate cancer. Journal of Clinical Nursing, 16, 734-741. doi:10.1016/j.apnr.2009.08.001
Birnie, K., & Robinson, J. (2010). Helping patients with localized prostate cancer reach treatment decisions. Canadian Family Physician, 56, 137-141.
Cooperberg, M. R., Carroll, P., & Klotz, L. (2011). Active surveillance for prostate cancer: Progress and promise. Journal of Clinical Oncology, 29, 3669-3676. doi:10.1200/JCO.2011.34.9738
Corcoran, A. T., Peele, P. B., & Benoit, R. M. (2010). Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer. Urology, 76, 703-709. doi:10.1016/j.urology.2009.12.071
Davison, B. J., & Goldenberg, S. L. (2011). Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU International, 108, 1787-1793. doi:10.1111/j.1464-410X.2011.10200.x
Davison, B. J., Oliffe, J. L., Pickles, T., & Mroz, L. (2009). Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncology Nursing Forum, 36, 89-96. doi:10.1188/09.ONF.89-96
Ervik, B., Nordoy, T., & Asplund, K. (2010). Hit by waves—Living with local, advanced, or localized prostate cancer treated with endocrine therapy or under active surveillance. Cancer Nursing, 33, 382-389. doi:10.1097/NCC.0b013e3181d1c8ea
Gorin, M. A., Soloway, C. T., Eldefraway, A., & Soloway, M. S. (2011). Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology, 77, 588-591. doi:10.1016/j.urology .2010.10.039
Hayes, J. H., Ollendorf, D. A., Pearson, S. D., Barry, M. J., Kantoff, P. W., Stewart, S. T., … McMahon, P. M. (2010). Active surveillance compared with initial treatment for men with low-risk prostate cancer: A decision analysis. JAMA, 304, 2373-2380. doi:10.1001/jama.2010.1720
Hedestig, O., Sandman, P., & Widmark, A. (2003). Living with untreated localized prostate cancer: A qualitative analysis of patient narratives. Cancer Nursing, 26, 55-60. doi:10.1097/00002820-2003 02000-00008
Hegarty, J., & Bailey, D. E. (2011). Active surveillance as a treatment option for prostate cancer. Seminars in Oncology Nursing, 27, 260-266. doi:10.1016/j.soncn.2011.07.004
Kazer, M. W., Bailey, D. E., Colberg, J., Kelly, W. K., & Carroll, P. (2011). The needs for men undergoing active surveillance (AS) for prostate cancer: Results of a focus group study. Journal of Clinical Nursing, 20(3-4), 581-586. doi:10.1111/j.1365-2702.2010.03489.x
Kazer, M. W., Bailey, D. E., Sanda, M., Colberg, J., & Kelly, W. K. (2011). An Internet intervention for management of uncertainty during active surveillance for prostate cancer. Oncology Nursing Forum, 38, 560-568. doi:10.1188/11.ONF.561-568
Kazer, M. W., Bailey, D. E., & Whittemore, R. (2010). Out of the black box: Expansion of a theory-based intervention to self-manage the uncertainty associated with active surveillance (AS) for prostate cancer. Research and Theory for Nursing Practice, 24, 101-112.
Kilpatrick, F. P., & Cantril, H. (1960). Self-anchoring scaling: A measure of individual's unique reality worlds. Journal of Individual Psychology, 16, 158-173.
Klotz, L. (2010). Active surveillance for prostate cancer: Patient selection and management. Current Oncology, 17(Suppl. 2), S11-S17. doi:10.3747/co.v17i0.713
Klotz, L., Zhang, L., Lam, A., Nam, R., Mamedov, A., & Loblaw, A. (2010). Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. Journal of Clinical Oncology, 28, 126-131. doi:10.1200/JCO.2009.24.2180
Konety, B. R. (2009). Prostate specific antigen screening and active surveillance in the elderly. Journal of Urology, 181, 1534-1535. doi:10.1016/j.juro.2009.01.065
Lawrentschuk, N., & Klotz, L. (2011). Active surveillance for low-risk prostate cancer: An update. Nature Reviews. Urology, 8, 312-320.
Madsen, L. T., & Symes, L. (2012). A concept analysis on active surveillance. Unpublished manuscript.
Mishel, M. H. (1990). Reconceptualization of the Uncertainty of Illness Theory. Image: The Journal of Nursing Scholarship, 22, 256-262. doi:10.1111/j.1547-5069.1990.tb00225.x
Mishel, M. H. (1997). Uncertainty in acute illness. Annual Review of Nursing Research, 15, 57-80.
Mishel, M. H., Belyea, M., Germino, B. B., Stewart, J. L., Bailey, D. E., Robertson, C., & Mohler, J. (2002). Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: Nurse-delivered psychoeducational intervention over the telephone. Cancer, 94, 1854-1866. doi:10.1002/cncr.10390
Oliffe, J. L., Davison, B. J., Pickles, T., & Mroz, L. (2009). The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qualitative Health Research, 19, 432-443. doi:10.1177/1049732309332692
Roberts, C. B., Albertsen, P. C., Shao, Y. H., Moore, D. F., Mehta, A. R., Stein, M. N., & Lu-Yao, G. (2011). Patterns and correlates of prostate cancer treatment in older men. American Journal of Medicine, 124, 235-243. doi:10.1016/j.amjmed.2010.10.016
Roy, S. C. (2009). The Roy Adaptation Model (3rd ed.). Upper Saddle River, NJ: Pearson.
Schacham, S. (1983). A shortened version of the Profile of Mood States. Journal of Personality Assessment, 47, 305-306. doi:10.1207/s15327752jpa4703_14
Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29. doi:10.3322/caac.20138
Stangelberger, A., Waldert, M., & Djavan, B. (2008). Prostate cancer in elderly men. Reviews in Urology, 10, 111-119.
Thompson, I., & Klotz, L. (2010). Active surveillance for prostate cancer. JAMA, 304, 2411-2412. doi:10.1001/jama.2010.1761
Van den Bergh, R. C., Essink-Bot, M., Roobol, M. J., Wolters, T., Schroder, F. H., Bangma, C. H., & Steyerberg, E. W. (2009). Anxiety and distress during active surveillance for early prostate cancer. Cancer, 115, 3868-3878. doi:10.1002/cncr.24446
Wallace, M. (2003). Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncology Nursing Forum, 30, 303-309. doi:10.1188/03.ONF.303-309
Walsh Scura, K., Budin, W., & Garfing, E. (2004). Telephone social support and education for adaptation to prostate cancer: A pilot study. Oncology Nursing Forum, 31, 335-338. doi:10.1188/04.ONF.335-338